AngioDynamics, Inc. (ANGO) vs Annexon, Inc. (ANNX)
A side-by-side comparison of AngioDynamics, Inc. and Annexon, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANGO
AngioDynamics, Inc.
$14.75HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
ANNX
Annexon, Inc.
$4.22HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Total return — ANGO vs ANNX
growth of $100 · dividends reinvested · last 6yANGO +64.4% (+8.6%/yr)ANNX -76.4% (-21.4%/yr)ANGO compounded faster over this window
Log scale — wide-divergence pair
ANGO ANNX
ANGO vs ANNX: by the numbers
- •ANNX is the larger company ($691M vs $610M market cap).
- •Both run net losses; ANNX's is the smaller (0.00% vs -11.48% net margin).
Metrics side by side
Valuation
| Metric | ANGO | ANNX |
|---|---|---|
| P/S ratio | 1.90 | N/A |
| P/B ratio | 3.57 | 3.72 |
| FCF yield | 0.08% | N/A |
Profitability
| Metric | ANGO | ANNX |
|---|---|---|
| Gross margin | 54.62% | 0.00% |
| Operating margin | -12.47% | 0.00% |
| Net margin | -11.48% | 0.00% |
| ROE | -21.51% | -108.93% |
| ROIC | -20.75% | -101.43% |
Growth (annualized)
| Metric | ANGO | ANNX |
|---|---|---|
| Revenue CAGR (5Y) | 1.93% | N/A |
| FCF CAGR (5Y) | -51.49% | N/A |
| Total return CAGR (5Y) | -10.80% | -26.29% |
Frequently asked
- How have ANGO and ANNX total returns compared?
- Over the past 5 years, ANGO delivered -10.80% and ANNX delivered -26.29% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.